Madrigal Pharmaceuticals, Inc. (MDGL): Operating Cash Flow
-$189.55M
Year ended 2025-12-31
-$197.72M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$189.55M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$455.57M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$324.23M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$224.86M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$183.92M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$157.56M | n/m | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | -$41.62M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$25.51M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$22.32M | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$17.61M | n/a | 2019-02-27, From 2016-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$189.55M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$268.58M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $185.22M | +189.3% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $348.20M | +58.4% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $109.84M | -30.4% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $257.63M | +2.4% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $179.55M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $329.32M | +60.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $142.00M | -28.4% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗